These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6106885)

  • 41. [Efficacy of the nadolol-bendroflumethiazide combination in the treatment of arterial hypertension].
    Zecchi P; Bellocci F; Santarelli P; Iannarelli M
    Clin Ter; 1986 Jan; 116(1):19-24. PubMed ID: 2870837
    [No Abstract]   [Full Text] [Related]  

  • 42. A comparison of propranolol and nadolol pharmacokinetics and clinical effects in thyrotoxicosis.
    Wilkinson R; Burr WA
    Am Heart J; 1984 Oct; 108(4 Pt 2):1160-7. PubMed ID: 6148879
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Twenty-four-hour blood pressure profile and blood pressure variability in untreated hypertension and during antihypertensive treatment by once-a-day nadolol.
    Mancia G; Ferrari A; Pomidossi G; Parati G; Bertinieri G; Grassi G; Gregorini L; di Rienzo M; Zanchetti A
    Am Heart J; 1984 Oct; 108(4 Pt 2):1078-83. PubMed ID: 6148866
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of digitalis on the heart rate during exercise in patients with atrial fibrillation.
    Aberg H; Ström G; Werner I
    Acta Med Scand; 1972 May; 191(5):441-5. PubMed ID: 5031539
    [No Abstract]   [Full Text] [Related]  

  • 45. Treatment of resting tremor by beta-adrenergic blockade.
    Foster NL; Newman RP; LeWitt PA; Gillespie MM; Chase TN
    Am Heart J; 1984 Oct; 108(4 Pt 2):1173-7. PubMed ID: 6148881
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-acting beta-adrenergic antagonists as preparation for surgery in thyrotoxicosis.
    Gerst PH; Fildes J; Baylor P; Zonszein J
    Arch Surg; 1986 Jul; 121(7):838-40. PubMed ID: 2872875
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Dynamic electrocardiogram in chronic atrial fibrillation treated with digitalis].
    Scardi S; Humar F; Cesanelli R; Pandullo C; Pivotti F
    G Ital Cardiol; 1991 May; 21(5):503-8. PubMed ID: 1936754
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of calcium antagonists and beta-adrenergic receptor blocking agents on cardiovascular rhythmicity.
    Bellomo G; Santucci S; Murrone A; Santambrogio L; Gennari M; Stangoni G
    Panminerva Med; 1988; 30(4):236-9. PubMed ID: 3244477
    [No Abstract]   [Full Text] [Related]  

  • 49. [The combination of digitalis and beta-blocking agents in the long-term therapy of atrial fibrillation].
    Iannone D; Pellegrini V; Damato S
    Boll Soc Ital Cardiol; 1978; 23(9):1597-600. PubMed ID: 45251
    [No Abstract]   [Full Text] [Related]  

  • 50. Use of a long acting peripheral beta blocker, nadolol, in panic disorder.
    Tollefson G
    J Clin Psychopharmacol; 1984 Jun; 4(3):170-1. PubMed ID: 6145730
    [No Abstract]   [Full Text] [Related]  

  • 51. Twenty-four-hour hemodynamic profile during treatment of essential hypertension by once-a-day nadolol.
    Mancia G; Ferrari A; Pomidossi G; Parati G; Bertinieri G; Grassi G; Gregorini L; Zanchetti A
    Hypertension; 1983; 5(4):573-8. PubMed ID: 6134670
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Differential impacts of achieved heart rate and achieved dose of β-blocker on clinical outcomes in heart failure with and without atrial fibrillation.
    Kato N; Kinugawa K; Teruhiko I; Hironori M; Hisataka M; Toshiro I; Masaru H; Atsushi Y; Nagai R
    Int J Cardiol; 2014 May; 173(2):331-3. PubMed ID: 24680244
    [No Abstract]   [Full Text] [Related]  

  • 53. Beta blockade with nadolol in patient with congestive heart-failure.
    Vukovich R; Sasahara A; Sanchez-Zambrano S; Belko J
    Lancet; 1978 Jan; 1(8056):162-3. PubMed ID: 87607
    [No Abstract]   [Full Text] [Related]  

  • 54. Beta-adrenergic blockers for the control of aggressive behaviors in patients with chronic schizophrenia.
    Sorgi PJ; Ratey JJ; Polakoff S
    Am J Psychiatry; 1986 Jun; 143(6):775-6. PubMed ID: 2872823
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Renal function in patients with essential hypertension receiving nadolol.
    Waal-Manning HJ; Hobson CH
    Br Med J; 1980 Aug; 281(6237):423-4. PubMed ID: 6107151
    [No Abstract]   [Full Text] [Related]  

  • 56. Successful treatment of low cardiac output syndrome with beta-adrenergic blockade because of improved effectiveness of an intra-aortic balloon pump.
    Lennon PF; Risk SC
    J Cardiothorac Vasc Anesth; 1995 Jun; 9(3):297-300. PubMed ID: 7669963
    [No Abstract]   [Full Text] [Related]  

  • 57. Nadolol instead of propranolol?
    Schiff AA
    Am J Psychiatry; 1983 Jul; 140(7):952-3. PubMed ID: 6134475
    [No Abstract]   [Full Text] [Related]  

  • 58. Nadolol use for cerebellar tremor.
    Edwards RV
    Am J Psychiatry; 1982 Nov; 139(11):1522. PubMed ID: 6127958
    [No Abstract]   [Full Text] [Related]  

  • 59. Nadolol: its use in the prophylactic treatment of migraine.
    Ryan RE; Ryan RE; Sudilovsky A
    Headache; 1983 Jan; 23(1):26-31. PubMed ID: 6131052
    [No Abstract]   [Full Text] [Related]  

  • 60. Effect of a long acting beta-adrenoceptor blocker on diurnal variation of cardiac dysrhythmias.
    Mir MA
    Postgrad Med J; 1986 Mar; 62(725):175-8. PubMed ID: 2872664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.